New Common Stock issuance upon emergence
Company: Core Scientific
The claim, verbatim
The company will issue approximately 166.0 million shares of New Common Stock as of the Effective Date, including 17.9 million shares for the Equity Rights Offering
Source (primary)
Core Scientific 8-K filed 2024-01-17 (SEC EDGAR, sec_filing)
View cached copy (2026-08-31)Live source ↗
Quote: “issue approximately 166.0 million shares of New Common Stock, including approximately 17.9 million shares of New Common Stock to be issued in connection with the Equity Rights Offering”
How we checked this
Checked on September 18, 2026. The cited source supports every part of this claim.
The filing states that as of the Effective Date the company will issue approximately 166.0 million shares of New Common Stock. It says this includes approximately 17.9 million shares for the Equity Rights Offering.
Confirmed in the source:
- The company will issue approximately 166.0 million shares of New Common Stock as of the Effective Date
- Approximately 17.9 million of those shares are to be issued in connection with the Equity Rights Offering
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312524008952/d598371d8k.htm) in full (24,353 characters, retrieved August 31, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 8-K filed 2024-01-17
Quote: “issue approximately 166.0 million shares of New Common Stock, including approximately 17.9 million shares of New Common Stock to be issued in connection with the Equity Rights Offering”